TheraCryf (FRA:8EV) Price-to-Free-Cash-Flow : N/A (As of May. 21, 2024)

TheraCryf Price-to-Free-Cash-Flow Chart

TheraCryf Annual Data
	Trend	Mar14	Mar15	Mar16	Mar17	Mar18	Mar19	Mar20	Mar21	Mar22	Mar23
Price-to-Free-Cash-Flow		Get a 7-Day Free Trial					-	-	-	-	-

TheraCryf Semi-Annual Data
	Mar13	Mar14	Mar15	Sep15	Mar16	Sep16	Mar17	Sep17	Mar18	Sep18	Mar19	Sep19	Mar20	Sep20	Mar21	Sep21	Mar22	Sep22	Mar23	Sep23
Price-to-Free-Cash-Flow	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of TheraCryf's Price-to-Free-Cash-Flow

For the Biotechnology subindustry, TheraCryf's Price-to-Free-Cash-Flow, along with its competitors' market caps and Price-to-Free-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

TheraCryf's Price-to-Free-Cash-Flow Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, TheraCryf's Price-to-Free-Cash-Flow distribution charts can be found below:

* The bar in red indicates where TheraCryf's Price-to-Free-Cash-Flow falls into.

TheraCryf Price-to-Free-Cash-Flow Calculation

TheraCryf's Price-to-Free-Cash-Flow ratio for today is calculated as

TheraCryf's Share Price of today is €0.0005.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. TheraCryf's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Sep. 2023 was €-0.01.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

TheraCryf  (FRA:8EV) Price-to-Free-Cash-Flow Explanation

Free Cash Flow is considered more important than earnings by value investors. The reason is because, in principle, only the net cash that can be taken from the business belongs to shareholders. This Free Cash Flow can be used to grow the business, reduce debt or return to shareholders in dividends or share buybacks.

In a DCF Calculation Free Cash Flow is used to determine the intrinsic value of companies.

Be Aware

In real business, Free Cash Flow can be affected by the change in accounts receivable, accounts payable, management's decision on expansion, etc. Therefore, investors should look at the Free Cash Flow over the longer term. Long-term average of Free Cash Flow is a more reliable indicator for real free cash flow.

TheraCryf Price-to-Free-Cash-Flow Related Terms

Thank you for viewing the detailed overview of TheraCryf's Price-to-Free-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.

TheraCryf (FRA:8EV) Business Description